Patents/Assignees

Xellia Pharmaceuticals APS

5 patents in portfolio

US12070485utility2024
Liquid Dalbavancin Compositions
0 cites
US12053502utility2024
Daptomycin Formulations
0 cites
US11925703utility2024
Liquid Composition Comprising Glucose
0 cites
US11759497utility2023
Daptomycin Formulations
0 cites
US11628200utility2023
Glycopeptide Compositions
0 cites